BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17001319)

  • 1. HRPAP20: a novel calmodulin-binding protein that increases breast cancer cell invasion.
    Karp CM; Shukla MN; Buckley DJ; Buckley AR
    Oncogene; 2007 Mar; 26(12):1780-8. PubMed ID: 17001319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.
    Mizuma M; Katayose Y; Yamamoto K; Shiraso S; Sasaki T; Yabuuchi S; Oda A; Masuda K; Rikiyama T; Onogawa T; Ohtsuka H; Motoi F; Egawa S; Unno M
    Anticancer Res; 2008; 28(5A):2669-77. PubMed ID: 19035293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer.
    Park SY; Jun JA; Jeong KJ; Heo HJ; Sohn JS; Lee HY; Park CG; Kang J
    Oncol Rep; 2011 Jun; 25(6):1677-81. PubMed ID: 21455583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between LKB1 gene and invasion-related factors of breast cancer cells].
    Zhuang ZG; Di GH; Hou YF; Liu G; Luo JM; Shen ZZ; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):81-4. PubMed ID: 17418010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
    Jones JL; Shaw JA; Pringle JH; Walker RA
    J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
    Sumida T; Itahana Y; Hamakawa H; Desprez PY
    Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of HRPAP20: a novel phosphoprotein that enhances growth and survival in hormone-responsive tumor cells.
    Karp CM; Pan H; Zhang M; Buckley DJ; Schuler LA; Buckley AR
    Cancer Res; 2004 Feb; 64(3):1016-25. PubMed ID: 14871833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion.
    Lee S; Park HI; Sang QX
    Biochem J; 2007 Apr; 403(1):31-42. PubMed ID: 17176253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation.
    Li W; Hardwick MJ; Rosenthal D; Culty M; Papadopoulos V
    Biochem Pharmacol; 2007 Feb; 73(4):491-503. PubMed ID: 17126818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
    Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM
    Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.
    Rucci N; Millimaggi D; Mari M; Del Fattore A; Bologna M; Teti A; Angelucci A; Dolo V
    Cancer Res; 2010 Aug; 70(15):6150-60. PubMed ID: 20631064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
    Merrell MA; Ilvesaro JM; Lehtonen N; Sorsa T; Gehrs B; Rosenthal E; Chen D; Shackley B; Harris KW; Selander KS
    Mol Cancer Res; 2006 Jul; 4(7):437-47. PubMed ID: 16849519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway.
    Hsieh MJ; Chen KS; Chiou HL; Hsieh YS
    Eur J Cell Biol; 2010 Aug; 89(8):598-606. PubMed ID: 20434230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
    Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
    Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
    Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
    Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
    Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
    Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the functional role of AF1Q in the progression of breast cancer.
    Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2008 Sep; 111(1):65-78. PubMed ID: 17929166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
    Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
    Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.